Dedicated to the
diagnosis and treatment
of hypercoagulable conditions
What we do
Clinical Practice and Education
King's Thrombosis Centre are proud to have been the primary exemplar centre within the VTE Network.
We are an experienced multi-disciplinary clinical academic team, conducting translational research in the field of thrombosis and haemostasis.
The King's Thrombosis Centre is a leading multidisciplinary clinical and research group dedicated to the diagnosis and treatment of hypercoagulable conditions.
We are a designated Haemophilia Centre and were the first National Venous Thromboembolism (VTE) Exemplar Centre, reflecting our national leadership in the prevention and treatment of VTE. Our clinical trials unit works in partnership with industry to develop new treatments for VTE prevention and treatment.
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials
The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome remain controversial.
Latest Research News